Literature DB >> 24491501

LPR: how different diagnostic tools shape the outcomes of treatment.

Yichen Wan1, Yan Yan2, Furong Ma3, Li Wang2, Peiquan Lu2, Allison Maytag4, Jack J Jiang4.   

Abstract

OBJECTIVE: To seek a deeper and more comprehensive understanding of two major diagnostic methods for laryngopharyngeal reflux by exploring whether and how differences exist before and after treatment between patients diagnosed by either Reflux Symptom Index (RSI) and Reflux Finding Score (RFS) or 24-hour pH monitoring.
MATERIALS AND METHODS: Two groups of patients who confirmed laryngopharyngeal reflux disease (LPRD) by either a combination of RSI and RFS (Questionnaire group, 35 patients) or 24-hour multichannel intraluminal impedance (MII) pH monitoring (pH Group, 23 patients) were recruited. All patients were prescribed esomeprazole 20 mg twice a day for 1 month. RSI, RFS, and acoustic parameters before and after treatment were compared between the two groups. Intrinsic correlations involving multiple parameters were investigated as well.
RESULTS: Except for excess throat mucus (P = 0.019) and subglottic edema (P = 0.042), most RSI and RFS items before treatment were not significantly different between the Questionnaire and pH Groups, and nearly all such items in both groups exhibited distinct remission after therapy (P < 0.05). Absolute value of remission in RSI after treatment was more prominent in pH Group than in the Questionnaire group (P = 0.007). Jitter (P = 0.252), shimmer (P = 0.815), and harmonics-to-noise ratio (P = 0.117) descended to normal value after treatment. Moderate to high levels of correlation were found between the patient's original status and the absolute value of remission in most items of RSI and RFS as well as voice parameters.
CONCLUSION: The 24-hour MII pH monitoring and a combination of RSI and RFS are quite competitive with each other in selecting LPRD patients. Although treatment worked out on nearly all the symptoms, laryngeal images and voice parameters, 24-hour MII pH seems to be more promising in a greater symptom relief. The extent of relief that can take place in most of the measurements is considerably determined by their initial status.
Copyright © 2014 The Voice Foundation. All rights reserved.

Entities:  

Keywords:  24-Hour multichannel intraluminal impedance pH monitoring; Laryngopharyngeal reflux; RSF; RSI

Mesh:

Substances:

Year:  2014        PMID: 24491501     DOI: 10.1016/j.jvoice.2013.12.004

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  5 in total

1.  Impact of age on laryngopharyngeal reflux disease presentation: a multi-center prospective study.

Authors:  Jérôme R Lechien; Camille Finck; Kathy Huet; Mohamad Khalife; Anne-Françoise Fourneau; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-17       Impact factor: 2.503

2.  Reply to the letter "Laryngopharyngeal reflux disease in the elderly".

Authors:  Jérôme R Lechien; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-04       Impact factor: 2.503

3.  Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study.

Authors:  Jérôme R Lechien; Kathy Huet; Mohamad Khalife; Anne-Françoise Fourneau; Camille Finck; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-26       Impact factor: 2.503

Review 4.  Voice outcomes of laryngopharyngeal reflux treatment: a systematic review of 1483 patients.

Authors:  Jérôme R Lechien; Camille Finck; Pedro Costa de Araujo; Kathy Huet; Véronique Delvaux; Myriam Piccaluga; Bernard Harmegnies; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-23       Impact factor: 2.503

5.  Treatment of laryngopharyngeal reflux disease: A systematic review.

Authors:  Jerome R Lechien; Francois Mouawad; Maria R Barillari; Andrea Nacci; Seyyedeh Maryam Khoddami; Necati Enver; Sampath Kumar Raghunandhan; Christian Calvo-Henriquez; Young-Gyu Eun; Sven Saussez
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.